Allianzgi Convertible & Income Fund II 2015 Q3 Institutional Investor Sentiment Better Than Expected

Sentiment for Allianzgi Convertible & Income Fund II (NYSE:NCZ)

Allianzgi Convertible & Income Fund II (NYSE:NCZ) institutional sentiment decreased to 1.36 in Q3 2015. Its down -0.42, from 1.78 in 2015Q2. The ratio has dropped, as 32 active investment managers increased and started new equity positions, while 18 sold and decreased their equity positions in Allianzgi Convertible & Income Fund II. The active investment managers in our partner’s database now possess: 6.41 million shares, up from 5.04 million shares in 2015Q2. Also, the number of active investment managers holding Allianzgi Convertible & Income Fund II in their top 10 equity positions was flat from 1 to 1 for the same number . Sold All: 5 Reduced: 13 Increased: 17 New Position: 15.

AllianzGI Convertible & Income Fund II is a closed-end fund. The company has a market cap of $364.98 million. The Fund investment objective is to provide total return through a combination of capital appreciation and high current income. It currently has negative earnings. The Funds attempt to achieve this objective by investing in a portfolio of convertible securities and non-convertible income-producing securities.

About 33,504 shares traded hands. Allianzgi Convertible & Income Fund II (NYSE:NCZ) has declined 15.74% since September 3, 2015 and is downtrending. It has underperformed by 20.40% the S&P500.

Doliver Capital Advisors Inc. holds 2.2% of its portfolio in Allianzgi Convertible & Income Fund II for 560,973 shares. Investors Capital Advisory Services owns 662,354 shares or 0.7% of their US portfolio. Moreover, Cornerstone Advisors Inc has 0.37% invested in the company for 295,600 shares. The New York-based Metlife Securities Inc has invested 0.12% in the stock. Landscape Capital Management L.L.C., a New Jersey-based fund reported 120,099 shares.#img1#

Allianzgi Convertible & Income Fund II - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Add Comment